|
2023 Book Chapter An enzymatic activity assay for heparanase that is useful for evaluating clinically relevant inhibitors and studying kineticsHammond, Edward and Ferro, Vito (2023). An enzymatic activity assay for heparanase that is useful for evaluating clinically relevant inhibitors and studying kinetics. Methods in molecular biology. (pp. 227-238) edited by Nikos K. Karamanos. New York, NY United States: Humana Press. doi: 10.1007/978-1-0716-2946-8_16 |
|
2020 Book Chapter Mucopolysaccharidosis type II (Hunter syndrome): clinical and biochemical aspects of the disease and approaches to its diagnosis and treatmentMohamed, Shifaza, He, Qi Qi, Singh, Arti A. and Ferro, Vito (2020). Mucopolysaccharidosis type II (Hunter syndrome): clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment. Advances in carbohydrate chemistry and biochemistry. (pp. 71-118) edited by David C. Baker. Cambridge, MA, United States: Academic Press. doi: 10.1016/bs.accb.2019.09.001 |
|
2015 Book Chapter Synthetic approaches to l-Iduronic Acid and l-Idose: key building blocks for the preparation of glycosaminoglycan oligosaccharidesMohamed, Shifaza and Ferro, Vito (2015). Synthetic approaches to l-Iduronic Acid and l-Idose: key building blocks for the preparation of glycosaminoglycan oligosaccharides. Advances in carbohydrate chemistry and biochemistry. (pp. 21-61) edited by David C. Baker and Derek Horton. Waltham, MA, United States: Academic Press. doi: 10.1016/bs.accb.2015.07.001 |
|
2006 Book Chapter Heparanase as a Target for Anticancer Therapeutics: New Developments and Future ProspectsHammond, E., Bytheway, I. and Ferro, V. (2006). Heparanase as a Target for Anticancer Therapeutics: New Developments and Future Prospects. New Developments in Therapeutic Glycomics. (pp. 251-282) edited by Maryse Delehedde and Hugues Lortat-Jacob. Trivandrum, India: Research Signpost. |
